Company Overview and News

36
Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now?

22h zacks
Making its debut on 06/16/2006, smart beta exchange traded fund WisdomTree International High Dividend Fund (DTH - Free Report) provides investors broad exposure to the Broad Developed World ETFs category of the U.S. equity market.
FP BP BP BPAQF EFA BP.A BP.B IEFA

57
Deep-Water Drilling Is Back - Bloomberg

2018-06-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BP RDS.B RDS.A CVX RYDBF BP RDSB BPAQF RDSA RYDAF BP.A BP.B

48
Is WisdomTree International LargeCap Dividend Fund (DOL) a Hot ETF Right Now?

2018-06-21 zacks
Designed to provide broad exposure to the Broad Developed World ETFs category of the U.S. equity market, the WisdomTree International LargeCap Dividend Fund (DOL - Free Report) is a smart beta exchange traded fund launched on 06/16/2006.
BP MS.PRI MS.PRK MS.PRE MS.PRF BP MS.PRG MS BPAQF MS.PRA BP.A BP.B

37
UPDATE 1-UK Stocks-Factors to watch on June 21

2018-06-21 reuters
June 21 (Reuters) - Britain’s FTSE 100 index is seen opening 49 points higher at 7,676 on Thursday, according to financial bookmakers, with futures up 0.28 percent ahead of the cash market open.
DSITF BP DXCPY BC88 BP.A CMPGF BP.B BP CPG UUGRY CMPGY DC BPAQF UU CHG UUGWF

36
OPEC works toward deal as Saudis propose plan for higher output

2018-06-21 thestar.com.my
KUWAIT: The odds of OPEC reaching an oil-production deal increased as Iran edged away from a threat to veto any agreement that would raise output and Saudi Arabia put forward a plan that would add about 600,000 barrels a day to the global market. At the end of a day of diplomatic back-and-forth in Vienna on Wednesday, delegates were increasingly positive that a deal would be reached at Friday’s meeting of the Organization of Petroleum Exporting Countries.
BP BP BPAQF BP.A BP.B

42
Argentina's Shale Potential Hit As Small Firms Struggle For Funds

2018-06-20 rigzone
BUENOS AIRES, June 19 (Reuters) - Small shale producers, which powered development of the sector in the United States, are struggling to break into Argentina due to financing difficulties and lack of infrastructure, analysts and industry sources say.
FP BP XOM MVN BP BPAQF MDLNF BP.A BP.B

36
OPEC races to salvage oil deal after Iran, Saudi clash

2018-06-20 worldoil
With two days before OPEC ministers formally meet in Vienna to decide on policy, delegates were in closed-door talks to find a way to boost production and ease consumer anxiety about high oil prices.
BP BP BPAQF BP.A BP.B

36
OPEC Races to Salvage Oil Deal After Iran and Saudi Clash

2018-06-20 rigzone
(Bloomberg) -- OPEC officials meeting in Vienna raced to salvage an oil-production deal on Wednesday after Iran said it was likely to reject any agreement that raised output from the group.
BP BP BPAQF BP.A BP.B

51
Gevo, Inc. Stock Skyrockets Monday on EPA News

2018-06-19 investorplace
Gevo, Inc. (NASDAQ:GEVO) had a wild Monday as the company’s stock went gangbusters following some good news from the Environmental Protection Agency (EPA).
GEVO BP GPRE REX BP BPAQF BP.A DWDP BP.B

36
Home BP monitoring beats clinic measurement

2018-06-18 lifestyle.inquirer.net
Last week, I had the privilege to chair one of the plenary sessions at the annual convention of the European Society of Hypertension in Barcelona, Spain.
BP BP BPAQF BP.A BP.B

70
Gevo resumes trading after halt for volatility

2018-06-18 marketwatch
Shares of biofuel company Gevo Inc. soared more than 270% Monday, after the Environmental Protection Agency raised the amount of isobutanol used for on-road use in cars to a 16 percent blend level from a previous 12.5 percent blend level. The approval came at the request of Delaware-based Butamax Advanced Biofuels LLC, a joint venture between BP Plc and DuPont . "At Gevo we have been developing the markets for isobutanol containing gasoline, in particular to meet the demand for the "ethanol free" segment of the gasoline market," Gevo Chief Executive Patrick Gruber said in a statement.
GEVO GGVVW AMTX GEVWW GPRE FCELB BP BP.A BP.B ECHO FCEL BP REX BPAQF GEVNW GEVOW MLM TERP

63
Minister: Uruguay to Adopt Permanent Offer Process for Offshore Oil Blocks

2018-06-15 rigzone
BARILOCHE, Argentina, June 15 (Reuters) - Uruguay will move toward a permanent offer process for offshore oil blocks as other Latin American countries have done, after an April auction failed to attract bids, Industry, Energy and Mining Minister Carolina Cosse said in an interview this week.
RDS.B RDS.A XOM BP RDSB RDSA GLPEF BP.A BP.B BP RYDBF TLW BPAQF RYDAF GLPEY

63
Adviser: Leftist Presidential Hopeful Would End Brazil Oil Refining Monopol

2018-06-14 rigzone
SAO PAULO, June 13 (Reuters) - The leading leftist candidate in Brazil's presidential race, Ciro Gomes, would end the refining monopoly of state oil company Petroleo Brasileiro SA, a senior Gomes adviser told Reuters.
BP RDS.B RDS.A XOM RYDBF BP RDSB BPAQF RDSA RYDAF BP.A BP.B

63
Leftist presidential hopeful would end Brazil oil refining monopoly -adviser

2018-06-13 reuters
SAO PAULO (Reuters) - The leading leftist candidate in Brazil’s presidential race, Ciro Gomes, would end the refining monopoly of state oil company Petroleo Brasileiro SA, a senior Gomes adviser told Reuters.
BP RDS.B RDS.A XOM RYDBF BP RDSB BPAQF RDSA RYDAF BP.A BP.B

57
Oil companies ask to throw out New York's climate change lawsuit

2018-06-13 worldoil
ConocoPhillips, ExxonMobil Corp. and Chevron Corp. argued in a hearing Wednesday that the federal court in Manhattan isn’t a proper forum to regulate the global activity of the energy industry. They urged U.S. District Judge John Keenan to follow the example of other judges who have rejected similar suits.
BP RDS.B RDS.A CVX RYDBF BP RDSB BPAQF RDSA RYDAF BP.A BP.B

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...